PHARMACEUTICALS AND DRUG DEVELOPMENT
New mRNA Flu Shot In US Offers Nearly 30% More Protection For Adults 50+
A new flu vaccine has been approved in the US for adults 50+, bringing mRNA technology into seasonal flu prevention and raising questions about whether it offers stronger protection.
USOHIOUNITED STATESJOHNS HOPKINS UNIVERSITYUNIVERSITY OF CALIFORNIA LAW SAN FRANCISCOMODERNA